Navigation Links
Receptors involved in corneal clarity identified

The researchers at the Aberdeen University have found out molecules that could aid in the treatment of cancer, heart diseases and other serious disorders//.

The expression of this molecule, sflt-1, a free-floating receptor for vascular endothelial growth factor A, prevents the formation of vision obstructing blood vessels, thus keeps the cornea clear.

According to the researchers, this discovery could help in the development of new drugs, new therapies for eye diseases and eye injuries. The Aberdeen team and colleagues at the Medical College of Georgia and the University of Kentucky in the US conducted this research.

Dr Martin Collinson, senior lecturer at the University of Aberdeen, said, "The molecule is an amazing finding". He added: "The cornea is widely used by scientists who hope to study how blood vessels grow or how to inhibit the growth of new blood vessels. "This knowledge will help to treat diseases like cancer, heart disease, rheumatoid arthritis, stroke and eye disorders like macular degeneration. "The cornea is our window on the world. If it contained blood vessels it would not be transparent and we would not be able to see. "If you study a normal eye you will see blood vessels in the whites of the eye but these stop at the cornea."

The cornea could get vascularised or form blood vessels due to disease or injury. Tumors are able to grow due to their capacity to attract blood vessels. Hence, vascularisation is crucial in diseases like cancer.
GYT
'"/>




Page: 1

Related medicine news :

1. Effects Of Certain Food Related To Single Pain Receptors
2. Inhibitor That Blocks Host Receptors Found To be Effective In Treating Anthrax
3. Max Planck Researchers Incorporate Odorant Receptors into Artificial Membranes
4. Nitric oxide involved in high blood pressure
5. Scientists locate key hormone involved in appetite control
6. Risks involved in Procedural Sedation
7. Toxin causing Gastrointestinal problems identified
8. Gene Variant associated with Schizophrenia identified
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... More than ... Hep B United Philadelphia, and the Prevent Cancer Foundation held an event on National ... epidemic in the city of viral hepatitis, the leading cause of liver cancer. , ...
(Date:5/31/2016)... ... 2016 , ... St. Joseph Medical Center (SJMC) announced that ... enables physicians at SJMC’s two hospital campuses, downtown and in the Heights, to ... exchange. SJMC’s membership in the health information exchange underscores the hospital’s commitment to ...
(Date:5/31/2016)... ... May 31, 2016 , ... When MetLoop first demonstrated its ... something that contractors should have at their disposal on a daily basis. , ... Director of Contractor Programs. , As a result, Metloop and CertainTeed entered ...
(Date:5/31/2016)... ... May 31, 2016 , ... Spartan Bioscience ... enables unprecedented portability and convenience. , The Cube is exceptionally small—it takes up ... the Cube fits easily into any space, whether in a hospital, doctor’s office, ...
(Date:5/31/2016)... ... ... Like jewels in a crown, the multiple awards presented to Fayez Spa confirm ... day spa and one of Canada’s few accredited 5 Star Spas! , The ... spa services with hair and beauty services and has resulted in creating ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... , May 31, 2016 Aloe ... in food, cosmetics and pharmaceuticals, with global volume to ... US$ 1.6 Bn. Demand for aloe vera ... and yogurts will continue its upward momentum in 2016 ... also boost positive sentiment on aloe vera, with wide-ranging ...
(Date:5/31/2016)... Israel , May 31, 2016 ... its proprietary plant-based rhCollagen technology for tissue repair products ... Chief Scientist of Israel,s Ministry ... 12 million development project for 2016. The Chief Scientist,s grant ... year,s authorized grant, which totaled NIS 4.7 million.  ...
(Date:5/31/2016)... , May 31, 2016 ... research report with comparative analysis of Asthma therapy at ... action (MoA), route of administration (RoA) and molecule type, ... releases. It also reviews key players involved in the ... and discontinued projects. Complete report on H1 ...
Breaking Medicine Technology: